Search Results 311-320 of 10119 for SC
Participation eligibility · TNF inhibitors (adalimumab, certolizumab, etanercept, golimumab, or infliximab) · Abatacept (Orencia; IV or SC) · Tocilizumab (Actemra; ...
The purpose of this study is to evaluate effects on proteinuria and glomerular filtration rate of sibeprenlimab 400 mg subcutaneously (s.c.) Q 4 weeks in ...
B.Sc. (Hons), Biochemistry. Lancaster University. Lancaster, United Kingdom. Ph.D., Biochemistry and Molecular Biology. Class: 2020. Advisor: Mark A. McNiven, ...
Ilyas Aleem, M.D., M.Sc., was recently awarded the prestigious Cervical Spine Research Society traveling fellowship for 2019.
2019. Solinsky R, Donovan JM, Kirshblum SC. Charcot Spine following chronic spinal cord injury: an analysis of 201 published cases. Spinal Cord. 2019 ...
... [SC]), and an immunomodulator (oral methotrexate) on endoscopic remission in participants with newly-diagnosed Crohn's Disease (CD) stratified at higher risk ...
Approximately 90% of patients are from Florida, Georgia, or South Carolina. ... Farraye, M.D., M.Sc. Program Director. Alessandra Barahona Education Program ...
Hosp Pract (1995). 2014 Feb; 42(1):52-64. View PubMed; Mauck KF, Litin SC, Bundrick JB. Clinical pearls in perioperative medicine.
South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virgin Islands, Virginia, Washington, West Virginia, Wisconsin, Wyoming. Error Enter the ...
About this study. The purpose of this study is to assess the effectiveness of daratumumab SC in treating patients with monoclonal immunoglobulin deposits ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.